BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 34281949)

  • 1. Antithymocyte globulin-induced atypical haemorrhagic posterior reversible encephalopathy syndrome in severe aplastic anaemia.
    Panda T; Aggarwal M; Naranje P; Mahapatra M
    BMJ Case Rep; 2021 Jul; 14(7):. PubMed ID: 34281949
    [No Abstract]   [Full Text] [Related]  

  • 2. Antithymocyte globulin induced posterior reversible encephalopathy in aplastic anemia.
    Dayama A; Seth T; Mishra P; Mahapatra M
    Neurol India; 2013; 61(4):430-1. PubMed ID: 24005743
    [No Abstract]   [Full Text] [Related]  

  • 3. Posterior reversible encephalopathy syndrome following anti-lymphocyte globulin treatment for severe aplastic anaemia.
    Greaves P; Oakervee H; Kon SS; Jones R; Farah N
    Br J Haematol; 2006 Aug; 134(3):251. PubMed ID: 16848767
    [No Abstract]   [Full Text] [Related]  

  • 4. Guillain Barré syndrome precipitated by the use of antilymphocyte globulin in the treatment of severe aplastic anaemia.
    Kaya B; Davies CE; Oakervee HE; Silver NC; Gawler J; Cavenagh JD
    J Clin Pathol; 2005 Sep; 58(9):994-5. PubMed ID: 16126887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute renal failure following antithymocyte globulin therapy for aplastic anaemia-report of two cases and review of literature.
    Gupta N; Mahapatra M; Rathi S; Kapoor R; Singh A; Seth T; Mishra P
    Ann Hematol; 2011 Feb; 90(2):239-41. PubMed ID: 20544349
    [No Abstract]   [Full Text] [Related]  

  • 6. Antithymocyte globulin treatment of severe aplastic anaemia.
    Miller WJ; Branda RF; Flynn PJ; Howe RB; Ramsay NK; Condie RM; Jacob HS
    Br J Haematol; 1983 Sep; 55(1):17-25. PubMed ID: 6603864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term efficacy and safety of antithymocyte globulin treatment in elderly patients with acquired aplastic anaemia.
    Tjon JM; de Groot MR; Sypkens Smit SMA; de Wreede LC; Snijders TJF; Koene HR; Meijer E; Raaijmakers MHG; Schaap M; Raymakers R; Zeerleder SS; Halkes CJM
    Br J Haematol; 2018 Feb; 180(3):459-462. PubMed ID: 27714765
    [No Abstract]   [Full Text] [Related]  

  • 8. [Curative effect of antithymocyte globulin for aplastic anemia in 8 children].
    Zhao XL; DU L; Pan KL
    Zhongguo Dang Dai Er Ke Za Zhi; 2011 Sep; 13(9):760-2. PubMed ID: 21924031
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful desensitization to antithymocyte globulin in a child with aplastic anemia.
    Hall M; Hagemann TM
    Am J Health Syst Pharm; 2006 Sep; 63(17):1633-6. PubMed ID: 16914633
    [No Abstract]   [Full Text] [Related]  

  • 10. Antithymocyte globulin in the treatment of D-penicillamine-induced aplastic anemia.
    Kondo H; Narita K
    Int J Hematol; 2002 May; 75(4):385-7. PubMed ID: 12041669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute kidney injury with extreme hyperuricemia after antithymocyte globulin treatment in a kidney transplant recipient with underlying aplastic anemia: a case report.
    Park Y; Chung BH; Park CW; Kim YS; Yang CW
    BMC Nephrol; 2020 Jul; 21(1):251. PubMed ID: 32615929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Merkel cell carcinoma developing after antithymocyte globulin and cyclosporine therapy for aplastic anemia.
    Takabayashi M; Sakai R; Sakamoto H; Iemoto Y; Kanamori H; Inayama Y; Ishigatsubo Y
    Anticancer Drugs; 2003 Mar; 14(3):251-3. PubMed ID: 12634621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithymocyte globulin-induced acute renal failure.
    Levine JM; Lien YH
    Am J Kidney Dis; 1999 Dec; 34(6):1155. PubMed ID: 10585330
    [No Abstract]   [Full Text] [Related]  

  • 14. Meta-analysis of treatment with rabbit and horse antithymocyte globulin for aplastic anemia.
    Hayakawa J; Kanda J; Akahoshi Y; Harada N; Kameda K; Ugai T; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Ashizawa M; Sato M; Terasako-Saito K; Kimura SI; Kikuchi M; Yamazaki R; Kako S; Kanda Y
    Int J Hematol; 2017 May; 105(5):578-586. PubMed ID: 28078653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithymocyte globulin in the treatment of gold induced severe aplastic anemia.
    Alvaro-Gracia JM; Castañeda-Sanz S; Arranz R; Ariza A; Sabando P; Ossorio C
    J Rheumatol; 1988 Jan; 15(1):43-5. PubMed ID: 3127586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver function abnormality following treatment with antithymocyte globulin for aplastic anaemia.
    Killick SB; Marsh JC; Booth JC; Gordon-Smith EC
    Bone Marrow Transplant; 1997 Feb; 19(3):249-51. PubMed ID: 9028554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between horse and rabbit antithymocyte globulin as first-line treatment for patients with severe aplastic anemia: a single-center retrospective study.
    Atta EH; Dias DS; Marra VL; de Azevedo AM
    Ann Hematol; 2010 Sep; 89(9):851-9. PubMed ID: 20373101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment with antithymocyte globulin and cyclosporin A of a severe aplastic anaemia associated with an eosinophilic fasciitis.
    Bonnotte B; Chauffert B; Caillot D; Martin F; Lorcerie B
    Br J Rheumatol; 1998 Dec; 37(12):1358-9. PubMed ID: 9973169
    [No Abstract]   [Full Text] [Related]  

  • 19. Antithymocyte globulin treatment in patients with aplastic anemia: a prospective randomized trial.
    Champlin R; Ho W; Gale RP
    N Engl J Med; 1983 Jan; 308(3):113-8. PubMed ID: 6336819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporine-related brainstem atypical posterior reversible leukoencephalopathy syndrome following hematopoietic stem cell transplant.
    Yafour N; Krim A; Bouhass R; Bekadja MA
    Hematol Oncol Stem Cell Ther; 2016 Mar; 9(1):36-8. PubMed ID: 25979822
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.